first line chemotherapy
Showing 9976 - 10000 of >10,000
Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)
Recruiting
- Anemia
- Ferric Derisomaltose Injection
- Darbepoetin Alfa Injection
-
Anyang-si, Korea, Republic ofHallym University Medical Center
Mar 13, 2023
Ototoxic Hearing Loss Trial in Toronto (N-Acetyl Cysteine)
Recruiting
- Ototoxic Hearing Loss
- N-Acetyl Cysteine
-
Toronto, Ontario, CanadaOdette Cancer Centre, Sunnybrook Health Sciences Centre
Oct 24, 2022
Microcirculation, Diabetes Trial in Graz (pulse-synchronized negative pressure (PSNP) device, Control - no intervention)
Terminated
- Microcirculation
- Diabetes
- pulse-synchronized negative pressure (PSNP) device
- Control - no intervention
-
Graz, Styira, AustriaDivision of Plastic, Aesthetic and Reconstructive Surgery
Jul 7, 2022
PTSD Trial in Morningside (acupuncture)
Recruiting
- PTSD
- acupuncture
-
Morningside, MarylandMalcom Grow Medical Clinics and Surgery Center
May 31, 2023
Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)
Recruiting
- Endometrial Adenocarcinoma
- Comparison of adjuvant therapies
-
Helsinki, FinlandHelsinki University Hospital
Dec 8, 2022
NSCLC Trial in Tianjin (Ensartinib, Placebo)
Recruiting
- Non-small Cell Lung Cancer
- Ensartinib
- Placebo
-
Tianjin, ChinaTianJin Medical University Cancer Institute & Hospital
Jul 13, 2022
Out of Hospital Cardiac Arrest Without ST-segment Elevation Trial in Reims (Coronary Calcium Score and Coronary CT angiogram)
Not yet recruiting
- Out of Hospital Cardiac Arrest Without ST-segment Elevation
- Coronary Calcium Score and Coronary CT angiogram
-
Reims, FranceDamien JOLLY
Jul 18, 2023
Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Cytomegalovirus and Inflammation on Patient Symptoms and
Recruiting
- Ovarian Cancer
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 7, 2021
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Desmoid Trial in Zhengzhou (Anlotinib)
Not yet recruiting
- Desmoid
-
Zhengzhou, Henan, ChinaDepartment of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 4, 2022
Type2 Diabetes, Cognitive Impairment, Mild Trial in Kaohsiung (cognitive stimulation, as usual care)
Completed
- Type2 Diabetes Mellitus
- Cognitive Impairment, Mild
- cognitive stimulation
- as usual care
-
Kaohsiung, TaiwanYong-Kang Clinic
Jun 8, 2023
Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia
Recruiting
- Acute Leukemia
- No intervention, observation study
-
Hangzhou, Zhejiang, ChinaClinical research ethics committee of the first affiliated hospi
Oct 6, 2023
Prematurity; Extreme Trial in Birmingham (Vitamin D supplementation, No additional vitamin D supplementation)
Not yet recruiting
- Prematurity; Extreme
- Vitamin D supplementation
- No additional vitamin D supplementation
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 23, 2023
Chemotherapeutic Toxicity, Cardiotoxicity, Heart Failure Trial in Tainan (Prevention therapy, Rescue therapy)
Recruiting
- Chemotherapeutic Toxicity
- +4 more
- Prevention therapy
- Rescue therapy
-
Tainan, TaiwanNational Cheng Kung University Hospital
Jun 6, 2023
Female, Sports, Muscle Trial in Seville (Effect of music on the manifestation of strength)
Completed
- Female
- +3 more
- Effect of music on the manifestation of strength
-
Seville, SpainEducation Faculty
Sep 29, 2023
Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) Trial in France
Unknown status
- Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
- Inotuzumab ozogamicin (INO)
-
Amiens, France
- +34 more
Aug 10, 2020
Septic Shock, Sepsis Trial in Colatina, Criciúma (Paroxetine)
Active, not recruiting
- Septic Shock
- Sepsis
-
Colatina, Espirito Santo, Brazil
- +1 more
Feb 13, 2023
Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)
Recruiting
- Neuroendocrine Tumours (NET)
- Neuroendocrine Carcinomas (NEC)
-
Santiago De Compostela, Galicia, Spain
- +4 more
Aug 1, 2022
Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage
Recruiting
- Basaloid Squamous Cell Carcinoma
- +7 more
- Cisplatin
- +5 more
-
Birmingham, Alabama
- +469 more
Jan 28, 2023
Advanced Solid Tumor, Lymphoma Trial in India, United States (GRC 54276, GRC 54276 + Pembrolizumab, GRC 54276 + Atezolizumab)
Recruiting
- Advanced Solid Tumor
- Lymphoma
- GRC 54276
- +2 more
-
Milwaukee, Wisconsin
- +7 more
May 26, 2023